(Press-News.org) Bad Hofgastein, 6 October 2010 -- European patients are in many countries, in fact, limited in their individual choice of medically assisted reproduction (MAR) treatment, experts from the European Society of Human Reproduction and Embryology (ESHRE) stressed today at the European Health Forum Gastein (EHFG).
The EHFG is the most important conference on health care policy in the EU. This year it has attracted about 600 decision-makers from more than 40 countries in the fields of health care policy, research, science, and business as well as from patients' organizations.
During an ESHRE workshop the political, professional, industrial and patient perspectives highlighted the problems related to the patchwork of MAR regulation in Europe. The regulatory diversity in MAR is attributed to the religious, cultural, social, ethical and moral attitudes prevalent in individual countries towards human life and its origins. In particular, gamete and embryo donation, surrogacy and preimplantation genetic diagnosis are hot spots in MAR regulation in Europe.
Demand for infertility treatment on the rise
The field of MAR is subject to the EU directive 2004/23/EC on quality and safety of human tissues and cells. "19 Member States have specific legislations in place for MAR, in the remaining eight countries, MAR is covered by the general health legislation," said Isabel de la Mata from the European Commission. "The organization of health systems is the exclusive competence of the members, meaning the legally allowed forms of treatment, the eligibility criteria and the reimbursement of treatments all vary between the Member States."
And yet demand for MAR treatment is on the rise in Europe. The latest survey by ESHRE - the only one of its kind in Europe – found that 494,599 treatment cycles were performed in Europe in 2006 compared to 203,893 cycles ten years earlier. The number of clinics reporting to the survey increased from 482 to 1,016 during the same period. In several European countries 2-5% of children are born after MAR, with every one in six couples seeking some sort of medical assistance in order to achieve a pregnancy.
30,000 couples seek treatment outside their home countries
"Due to the inequality of reimbursement and treatment unavailability, many patients seek treatment outside their home country, often putting themselves and their unborn babies at risk," explained Clare Lewis Jones, Chair of Fertility Europe, the umbrella organization of patient associations in Europe. Cross border travel for reproductive care is becoming a relevant phenomenon in Europe. A recent study by ESHRE showed that an estimated 11,000 to 14,000 patients go abroad for treatment each year in the six European countries studied (Belgium, Czech Republic, Denmark, Switzerland, Spain and Slovenia). "We estimate that about 30,000 couples cross borders each year in Europe to receive assisted reproduction treatment," said Luca Gianaroli, chairman of ESHRE.
"Less restrictive reimbursement policies leading to increased accessibility and use of MAR would be incentives for the industry to increase development efforts in this area," said Joan-Carles Arce, Vice President of R&D at Ferring Pharmaceuticals. "In addition, funding of academia-industry collaborations would stimulate further research within MAR and facilitate that new treatment concepts are being developed and subsequently put into clinical practice. It would also have a beneficial impact on the drug development activities if pricing and reimbursement authorities rewarded innovation."
"ESHRE is concerned about the heterogeneity that still exists in Europe," explained Luca Gianaroli. "At the European level a serious and fundamental reflection of MAR legislation is necessary to ensure that treatments of proven benefit to patients and offspring are made available in Europe, irrespective of the patient's income, marital status and place of residence." ESHRE believes this discussion should take place together with professionals in the fields and patients.
INFORMATION:
Workshop 3 "Reproductive health – Individual choices in reproductive health": Organised by the European Society of Human Reproduction and Embryology (ESHRE). Wednesday, 6. October 2010
www.eshre.eu
www.ehfg.org
ESHRE Press Contact:
Hanna Hanssen
Tel: +32 22 636466
Mob: +32 473 353381
hanna@eshre.eu
Reproductive health: Checkerboard of infertility treatment in Europe
In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries
2010-10-07
ELSE PRESS RELEASES FROM THIS DATE:
Greatest warming is in the north, but biggest impact on life is in the tropics
2010-10-07
In recent decades documented biological changes in the far Northern Hemisphere have been attributed to global warming, changes from species extinctions to shifting geographic ranges. Such changes were expected because warming has been fastest in the northern temperate zone and the Arctic.
But new research published in the Oct. 7 edition of Nature adds to growing evidence that, even though the temperature increase has been smaller in the tropics, the impact of warming on life could be much greater there than in colder climates.
The study focused on ectothermic, or ...
From eye to brain
2010-10-07
LA JOLLA, CA-By comparing a clearly defined visual input with the electrical output of the retina, researchers at the Salk Institute for Biological Studies were able to trace for the first time the neuronal circuitry that connects individual photoreceptors with retinal ganglion cells, the neurons that carry visuals signals from the eye to the brain.
Their measurements, published in the Oct. 7, 2010, issue of the journal Nature, not only reveal computations in a neural circuit at the elementary resolution of individual neurons but also shed light on the neural code used ...
Blood pressure breakthrough holds real hope for treatment of pre-eclampsia
2010-10-07
Scientists have discovered a mechanism which raises blood pressure in pre-eclampsia, a potentially deadly condition which occurs during pregnancy.
After 20 years of research, scientists from the University of Cambridge have now cracked the first step in the main process that controls blood pressure. Their findings, published today in the journal Nature, are likely to have significant implications for the treatment of pre-eclampsia as well as high blood pressure (also known as hypertension).
Blood pressure is controlled by hormones called angiotensins, which cause ...
Research identifies the herbal supplements that are effective in treating anxiety
2010-10-07
A systematic review of research into the use of nutritional supplements for the treatment of anxiety disorders has found strong evidence for the use of extracts of passionflower or kava and combinations of L-lysine and L-arginine. Researchers writing in BioMed Central's open access Nutrition Journal pooled the results of 24 studies involving a total of more than 2000 participants, showing that some nutritional and herbal supplements can be effective, without the risk of serious side effects.
The research was carried out by Shaheen Lakhan and Karen Vieira from the Global ...
Stressed-out mums may worsen their child's asthma
2010-10-07
Mums who are often angry or irritated and those who suppress their emotional expressions can worsen the severity of their children's asthma symptoms, especially when the children are younger. Researchers writing in BioMed Central's open access journal BioPsychoSocial Medicine studied 223 mothers for a year , investigating how their stress levels, coping styles and parenting styles were associated with their 2 to 12 year old children's disease status.
Jun Nagano, from the Kyushu University Institute of Health Science, Fukuoka, Japan, worked with a team of researchers ...
Novel approach yields new insights into the causes of pre-eclampsia
2010-10-07
An exciting collaboration between the Universities of Cambridge and Nottingham has resulted in new insights into the hypertension that frequently blights pregnancy.
The results, published in the journal Nature [online 6th October], describe the solving of the first step in the principal process that controls blood pressure — the release of the hormone angiotensin from its source protein, angiotensinogen.
Every day, millions of people are treated with drugs which either block the production of angiotensin, (ACE inhibitors), or stop it from taking effect in the body once ...
Vitamin D deficiency rampant in patients undergoing orthopedic surgery, damaging patient recovery
2010-10-07
Almost 50 percent of patients undergoing orthopedic surgery have vitamin D deficiency that should be corrected before surgery to improve patient outcomes, based on a study by researchers at Hospital for Special Surgery (HSS) in New York City. Vitamin D is essential for bone healing and muscle function and is critical for a patient's recovery. The study appears in the October issue of The Journal of Bone and Joint Surgery.
"In the perfect world, test levels, fix and then operate," said Joseph Lane, M.D., professor of Orthopedic Surgery and chief of the Metabolic Bone Disease ...
Female Cantabrian bears and their young do not hibernate
2010-10-07
A team of Spanish scientists followed the brown bear population through the mountains of the Cantabrian Cordillera between 1998 and 2007 in order to find out about their hibernation habits, which had been questioned in historical documents. The results confirm that female bears with babies and independent young bears under the age of two do not usually hibernate, while the other bears follow normal hibernation patterns.
Brown bears (Ursus arctos) all over the world hibernate, but according to historical documents this is not always the case. The Libro de la Montería by ...
Reviving the FDA: NEJM perspective
2010-10-07
Washington, DC – In a Perspective piece published online today in the New England Journal of Medicine, Georgetown University School of Medicine family medicine physician Susan Okie gives a comprehensive overview of change, and planned change, within the Food and Drug Administration (FDA). The review comes as the FDA's commissioner, Margaret Hamburg, completes her first year as the agency's leader.
Okie writes that the FDA's priorities over the past year have included "finding ways to make the FDA more nimble and proactive, restoring its credibility and refocusing staff ...
Vultures use face flushing technique for instant status updates
2010-10-07
Tech savvy humans who use social media sites to instantly update their 'statuses', may be behaving like vultures who use 'face flushing' as a visible way of instantly updating their own status when interacting with peers and rivals. Research, published in Ethology, reveals how the ability to rapidly change skin colour is a key form of interaction for vultures, especially for displays of dominance.
The ability to rapidly change skin colour has been well documented in reptiles and fish, which use specialist cells to disperse and concentrate pigments. However, the ability ...
LAST 30 PRESS RELEASES:
Normalizing blood sugar can halve heart attack risk
Lowering blood sugar cuts heart attack risk in people with prediabetes
Study links genetic variants to risk of blinding eye disease in premature infants
Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain
AI can pick up cultural values by mimicking how kids learn
China’s ecological redlines offer fast track to 30 x 30 global conservation goal
Invisible indoor threats: emerging household contaminants and their growing risks to human health
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Germline pathogenic variants among women without a history of breast cancer
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Unique bond identified as key to viral infection speed
Indoor tanning makes youthful skin much older on a genetic level
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
Smarter tools for peering into the microscopic world
Applications open for funding to conduct research in the Kinsey Institute archives
Global measure underestimates the severity of food insecurity
Child survivors of critical illness are missing out on timely follow up care
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
Early relapse predicts poor outcomes in aggressive blood cancer
American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement
Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Supplemental nutrition assistance program policies and food insecurity
Switching immune cells to “night mode” could limit damage after a heart attack, study suggests
URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment
Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors
Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care
[Press-News.org] Reproductive health: Checkerboard of infertility treatment in EuropeIn a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries